MENU

Singapore “Flyer” Of The Week: Cordlife

Cordlife Group Limited (SGX: P8A), steals this week’s limelight for the Singapore “Flyer” of the week. The share price of the company surged 22.6% this week from Friday’s close of $1.085. At the time of writing, the shares are being exchanged at $1.33.

Cordlife is a provider of stem cell banking from cord blood and umbilical cord. It currently owns and operates two stem cell banks with full processing and cryopreservation storage facilities in Singapore and Hong Kong. Furthermore, Cordlife has a strategic investment in the only cord blood bank operating in Guangzhou, China and has affiliates that operate in India, Indonesia and the Philippines.

The company released its Financial Year 2013 (FY2013) results on 26th August 2013. The revenue increased from $30.275 million in FY2012 to S$34.70 million in FY2013, an improvement of 14.6%. The net profit surged 94.7% from $6.9 million in FY2012 to $13.5 million this year.

A final dividend of 1.0 Singapore cent per share will be dished out to shareholders. Together with the interim dividend of 1.0 cent that was paid out for 2nd Quarter 2013, the total dividend for the year was 2.0 Singapore cents per share.

The company just went public in March 2012 at a listing price of $0.495. It is up 168.7% since then. Currently, it is trading at a PE of 22.8 and gives a dividend yield of 1.5%.

Click here now  for your   FREE   subscription to   Take Stock  Singapore, The Motley Fool’s free investing newsletter. Written by   David Kuo ,   Take Stock Singapore   tells you exactly what’s happening in today’s markets, and shows how you can GROW your wealth in the years ahead.  

Like us on Facebook   to keep up-to-date with our latest news and articles. The Motley Fool’s purpose is to help the world invest, better.

The information provided is for general information purposes only and is not intended to be personalised investment or financial advice.  Motley Fool Singapore contributor Sudhan P doesn’t own shares in any companies mentioned.